In a study that closes a long-standing knowledge gap in fundamental science, researchers Boerge Hemmerling and Stephen Kane at the University of California, Riverside, have successfully measured the ...
An anaplastic lymphoma kinase (ALK)-targeted agent induced high response rates for adults with ALK-positive anaplastic large cell lymphoma (ALCL) who had failed on brentuximab vedotin (Adcetris), a ...
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE) One hundred sixteen patients met the inclusion criteria; ...
Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of ...
Patients with BRCA-mutant breast cancer had a significantly higher risk of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), a large cohort study showed. BRCA1/2 mutations conferred ...
Pediatric anaplastic large cell lymphoma (ALCL) is a rare but highly curable T-cell non-Hodgkin lymphoma, most often driven by anaplastic lymphoma kinase (ALK) translocations and marked by uniform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results